Anavex Life Sciences Corp (AVXL)

[crescentmotor]

These results deserve a current $5 Billion MC AVXL trading price of $70.00 per share

Wow--that would make the Street grossly inefficient, which is often the case. I think that $5 billion is reasonable for three indications, one of which has passed Phase 3. It's hard to believe AVXL is sitting at $10 even with the Street currently sitting on biotech valuations. Surely AVXL will be in the $35-$50 range before 2023 assuming further trial success in Parkinson's and AD?